PDT Partners, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 271 filers reported holding HAEMONETICS CORP in Q3 2022. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
PDT Partners, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2022$372,000
-75.0%
5,703
-75.8%
0.03%
-74.2%
Q1 2022$1,489,000
+140.5%
23,553
+240.9%
0.13%
+204.8%
Q2 2020$619,000
+87.0%
6,909
-16.8%
0.04%
+366.7%
Q3 2013$331,000
-68.2%
8,300
-67.0%
0.01%
-66.7%
Q2 2013$1,040,00025,1530.03%
Other shareholders
HAEMONETICS CORP shareholders Q3 2022
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders